Biologics target and suppress specific drivers of inflammation and work well in some patients to treat the symptoms of nasal polyposis.
![© Zhurkovich Ekaterina / shutterstock.com](https://www.enttoday.org/wp-content/uploads/2019/11/ENT_1119_pg1a-145x85.png)
The reboot approach significantly reduced nasal polyp recurrence for 30 months postoperatively compared to the current mucosa-sparing approach.
Can the use of steroid eluting stents play a positive role in treating post-surgery recurrent nasal polyposis in the clinic?